Ivonescimab for the Treatment of Thymic Cancer

Clinical trial NCT06980077 · RECRUITING

Trial details

NCT number: NCT06980077
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thymus Carcinoma

Start date: 2025-07-15
Primary completion: 2027-06-17
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.